Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 46

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 46
---
 Merger Proposal (Proposal 1) — The Merger Agreement” and “ Certain Related Agreements — CVR Agreement.” x

Q. Is interest payable with respect to the CVRs? No interest will accrue on any amounts payable on the CVRs to any CVR holder. Q. If the CVR payment is made, what will be the respective ownership percentages? The CVRs will not represent any equity or ownership interest in NLS or in any constituent company to the Merger. Q. Is the CVR payment secured or guaranteed? The CVR payment is neither secured nor guaranteed. Even if the Merger is completed, there is no guarantee that any proceeds will be paid to NLS shareholders under the CVR Agreement. For a more detailed description, see “ Risk Factors — Risks Related to the Merger.” Q. Can I sell the CVRs? No. The CVRs cannot be sold or transferred other than through a permitted transfer. For a more complete description of the transferability of the CVRs, please see the section entitled “ Certain Related Agreements — CVR Agreement” in this proxy statement/prospectus. Q.Who will be the directors of NLS following the Merger? At and immediately after the Effective Time of the Merger, subject to the approval of NLS shareholders, the NLS Board is expected to be composed of the individuals set forth in the table below. The directors shall serve until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal.

| Name                        |     | Age |     | Position(s)                                            |
| Ronen Twito                 |     |  50 |     | Executive Chairman nominee and Chief Executive Officer |
| Prof. Michel Revel, MD, PhD |     |  86 |     | Director nominee and Chief Scientific Officer          |
| Olivier Samuel              |     |  51 |     | Independent Director                                   |
| Eran Iohan                  |     |  54 |     | Independent Director nominee                           |
| Liora Oren                  |     |  47 |     | Independent Director nominee                           |
| Alexander C. Zwyer          |     |  55 |     | Director                                               |
| Tammy Galili                |     |  52 |     | Director nominee                                       |

Q.Who will be the executive officers of NLS immediately following the Merger? Immediately following the Merger, the executive officers’ team of NLS is expected to be composed as set forth below: